(3.238.130.97) 您好!臺灣時間:2021/05/10 12:58
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果

詳目顯示:::

我願授權國圖
: 
twitterline
研究生:李國維
研究生(外文):Kwo-Whei Lee
論文名稱:急性缺血性腦中風溶栓手術之療效評估
論文名稱(外文):Evaluation of the Outcome of Intra-arterial Thrombolysis Therapy in Acute Ischemia Stroke
指導教授:譚秀芬譚秀芬引用關係
學位類別:碩士
校院名稱:長榮大學
系所名稱:醫學研究所
學門:醫藥衛生學門
學類:醫學學類
論文種類:學術論文
論文出版年:2008
畢業學年度:96
語文別:中文
論文頁數:67
中文關鍵詞:腦血管疾病腦中風動脈溶栓尿素酶美國國家衛生研究院腦中風評估量表
外文關鍵詞:Cerebral vascular diseaseischemic strokeintra-arterial thrombolysisUrokinaseNIHSS
相關次數:
  • 被引用被引用:0
  • 點閱點閱:438
  • 評分評分:系統版面圖檔系統版面圖檔系統版面圖檔系統版面圖檔系統版面圖檔
  • 下載下載:0
  • 收藏至我的研究室書目清單書目收藏:1
中風長年高居國人死亡原因之第二位。中風可概分為出血性及缺血性兩大類。其中,缺血性中風高達七成。隨著診斷及醫療技術的進步,醫界一直致力提高中風療效,並減少併發症。
  依急性缺血性腦中風最新的標準治療,如果患者符合所有治療條件,可於中風後三小時內,進行靜脈rTPA溶栓治療。但臨床上,符合三小時黃金時間可治療的病例並不多。因此,另一種更積極的治療方式,患者前循環中風超過三小時但在六小時之內,後循環中風超過三小時但在十二小時之內,且符合所有條件,可直接以微導管於血管阻塞部位進行動脈溶栓手術。
  一九九五年的大型國際研究(NINDS)證實,以靜脈rTPA溶栓治療急性缺血性腦中風三個月後,有臨床療效。但動脈溶栓手術案例數目少,又缺乏大型國際合作研究,迄今仍非美國食品藥物管理局(FDA)認可的標準治療,僅允許於少數醫學中心針對個案建議施行。因此,各醫學中心提出的療效報告,結論並不一致。因此,本研究針對彰化基督教醫院單一機構的案例進行研究。
  本研究收集彰化基督教醫院二○○一至二○○七年間,急性缺血性腦中風接受溶栓手術之病例,共四十七例。取其中治療後有進步的病例(NIHSS進步4分以上),以回溯性分析,取以下七種變數:性別、年齡、血管阻塞部位、術後顱內有無出血、血管溶栓打通程度、施打劑量、溶栓手術治療前之中風程度。發現其中四種變數(血管阻塞部位、術後顱內有無出血、血管溶栓打通程度、溶栓手術治療前之中風程度),與進步相關。而另外三個變數(性別、年齡與施打劑量),則與進步無關。
  此外,在這四十七例中,有十例於術後發生顱內出血。為了找出影響術後顱內出血之因素,以助未來治療之判斷,因此,也採回溯性分析,發現唯有血管打通程度此變數,與術後顱內出血相關。而另五種變數(性別、年齡、血管阻塞部位、施打劑量、溶栓手術治療前之中風程度),則與術後顱內出血並無相關。
  最後,若以血管打通程度(依TIMI分級法,見表四),回溯性分析此四十七例,發現唯有術後顱內出血此變數與之相關,其他變數(性別、年齡、血管阻塞部位、施打劑量、溶栓手術治療前之中風程度)皆無相關。
The clinical presentations of acute ischemic stroke are heterogeneous and sometimes make the correct diagnosis difficult. In Taiwan, it has been the second leading cause of death since the 1970s and has been causing serious individual, family and social burden.
There was no standard treatment for acute ischemic stroke until the first international intra-venous r-TPA thrombolysis treatment study published in 1995. The study demonstrated that study groups which were administered r-TPA within three hours of onset had better clinical outcome after three months. However, the narrow therapeutic golden time window and the risk of post-treatment hemorrhage remain controversial and pose many treatment challenges.
The intra-arterial thrombolysis treatment for acute ischemic stroke opens wider therapeutic golden time window and has the opportunity of achieving good clinical result according to many individual studies. However, lack of sufficient international studies has made it difficult to come up with a widely accepted standard for clinical treatment.
To foster further understanding of the clinical result of acute intra-arterial thrombolysis (I.A.T.), we reviewed our single center experience of I.A.T for acute ischemic stroke patients who are ineligible for intravenous thrombolysis (I.V.T) treatment. There are total 47 cases ( M/F:29/18 ), the mean age is 58.17±15.15. The occlusive sites include 9 cases in basilar artery (19.1%), 15 cases in internal carotid artery (31.9%) and 23 cases in middle cerebral artery (48.9%).
Among these 47 cases, 33 show clinical improvement (NIHSS improves at least 4 points) when they were discharged from the hospital. For these 33 cases, there are no significant correlations between the improvement outcome and the patients’ age, sex, and the dosage of Urokinase administered. Significant correlations (p<0.05) observed between the improvement outcome and the patients’ initial NIHSS score, the occlusive site, the post-treatment hemorrhage and re-canalization status.
There are total 10 cases of delayed intracranial hemorrhage after the IAT treatment. Only one variable (re-canalization status) shows significant correlation. Other variables (age, sex, occlusive site, the dosage of Urokinase administered, and the patient’s initial NIHSS score) do not show any significant correlation.
We use the TIMI grade system to evaluate the re-canalization status. Among all the 47 cases, 9 cases are in the range of TIMI 0-1. The other 19 cases are in TIMI 2 and 19 cases are in TIMI 3. We evaluate the following variables (age, sex, occlusive site, the dosage of Urokinase administered, and the initial NIHSS score) but there are no significant correlations between the re-canalization status and these variables.
中文摘要.................................................1
英文摘要..................................................3
重要英文名詞縮寫對照....................................6
第一章 緒論..............................................7
第一節 研究緣起..................................7
第二節 研究目的..................................7
第二章 研究材料與方法...................................9
第一節 研究材料...................................9
第二節 顱內血管溶栓治療手術過程說明.............11
第三節 臨床評估..................................12
第四節 研究方法..................................12
第五節 資料處理與分析方法........................13
第三章 結果............................................14
第一節 與溶栓術後進步相關之變數..................14
第二節 與溶栓術後出血相關之變數..................17
第三節 與血管溶通程度相關之變數..................19
第四章 討論............................................23
第一節 與溶栓術後進步相關之變數探討..............24
第二節 與溶栓術後出血相關之變數探討..............28
第三節 與血管溶通程度相關之變數探討...............30
第四節 研究限制..................................32
參考文獻................................................33
表目錄...................................................39
表一、行政院衛生署公佈95年度台灣地區死因統計結果.39
表二、研究基本資料................................40
表三、NIH Stroke Scale 美國國家衛生研究院腦中風評估.41
表四. TIMI grade system...........................44
圖目錄..................................................45
圖一、性別與NIHSS指數進步程度之統計相關性 .......45
圖二、年齡與NIHSS指數進步程度之統計相關性 .......46
圖三、使用溶栓劑劑量與NIHSS指數進步程度之統計..47
圖四、進步程度與治療前NIHSS指數之統計相關性 .....48
圖五、血管阻塞部位與NIHSS指數進步程度之統計相關性.49
圖六、術後出血與NIHSS指數進步程度之統計相關性 ....50
圖七、血管打通程度與NIHSS指數進步程度之統計相關性.51
圖八、術後出血與性別之統計相關性..................52
圖九、術後出血與年齡之統計相關性..................53
1.The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.

2.The NINDS t-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke 1997;28:2109-2118.

3.The TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial. N Engl J Med 1985;312:932-936.

4.The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings: TIMI Study Group. N Engl J Med 1985;312:932-936.

5.Albers GW, Bates VE, Clark WM, et al. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA 2000;283:1145-1150.

6.Archer CR, Horenstein S. Basilar artery occlusion: clinical and radiographic correlation. Stroke 1977;8:383-391.

7.Arnold M, Schroth G, Nedeltchev K, et al. Intra-arterial thrombolysis in 100 patients with acute stroke due to middle cerebral artery occlusion. Stroke 2002;33:1828-1833.

8.Arnold M, Nedeltchev K, Schroth G, et al. Clinical and radiological predictors of recanalisation and outcome of 40 patients with acute basilar artery occlusion treated with intra-arterial thrombolysis. J Neurol Neurosurg Psychiatry 2004;75:857-62.

9.Arnold M, Nedeltchev K, Remonda L, et al. Recanalisation of middle cerebral artery occlusion after intra-arterial thrombolysis: different recanalisation grading systems and clinical functional outcome. J. Neurol. Neurosurg. Psychiatry 2005;76:1373-1376.

10.Becker K, Monsein L, Ulatowski J, et al. Intra-arterial thrombolysis in vertebrobasilar occlusion. AJNR 1996;17:255-262, F

11.Bendszus M, Urbach H, Ries F, et al. Outcome after local intra-arterial fibrinolysis compared with the natural course of patients with a dense middle cerebral artery on early CT. Neuroradiology 1998;40:54-58.

12.Berger C, Fiorelli M, Steiner T, et al. Hemorrhagic transformation of ischemic brain tissue asymptomatic or symptomatic? Stroke 2001;32:1330-1335.

13.Bockenheimer St, Reinhuber F, Mohs C. Intra-arterial thrombolysis. Radiology 1991;31:210-215.

14.Brekenfeld C, Remonda L, Nedeltchev K, et al. Symptomatic intracranial haemorrhage after intr-arterial thrombolysis in acute ischaemic stroke: assessment of 294 patients treated with Urokinase. J Neurol Neurosurg Psychiatry 2007;78:280-285.

15.Bruckmann H, Ferbert A, del Zoppo GJ, et al. Acute basilar thrombosis: angiologic-clinical comparison and therapeutic implications. Acta Radiol 1987;369(suppl):38-42.

16.Buchan AM, Barber PA, Newcommon N, et al. Effectiveness of t-PA in acute ischemic stroke: outcome relates to appropriateness. Neurology 2000;54:679-684.

17.Burnette WC, Nesbit GM, Barnwell SL. Intra-arterial thrombolysis for acute stroke. Neuroimaging Clin N Am 1999;9:491-508.

18.Choi JH, Bateman BT, Mangla S, et al. Endovascular recanalization therapy in acute ischemic stroke. Stroke 2006;37:419-424.

19.Edwards MT, Murphy MM, Geraghty JJ, et al. Intra-arterial cerebral thrombolysis for acute ischemic stroke in a community hospital. AJNR 1999;20:1682-1687.

20.Ezaki Y, Tsutsumi K, Onizuka M, et al. Retrospective analysis of neurological outcome after intra-arterial thrombolysis in basilar artery occlusion. Surg Neurol 2003;60:423-429.

21.Fisher M, Garcia JH. Evolving stroke and the ischemic penumbra. Neurology 1996;47:884-888.

22.Fiorelli M, Bastianello S, von Kummer R, et al. Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-monthe outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. Stroke 1999;30:2280-2284.

23.Flint AC, Duckwiler GR, Budzik RF, et al. Mechanical thrombectomy of intracranial internal carotid occlusion: pooled results of the MERCI and multi MERCI part I trials. Stroke 2007;38:1274-1280.

24.Furlan A, Higashida R, Wechsler L, et al, for the PROACT Investigators. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. JAMA 1999;282:2003-2011.

25.Gonner F, Remonda L, Mattle H, et al. Local intr-arterial thrombolysis in acute ischemic stroke. Stroke 1998;29:1894-1900.

26.Gress D. Intra-arterial thrombolysis for cerebral infarction: to treat or not to treat, and how? AJNR 1999;20:1194-1196.

27.Hacke W, Kaste M, Fieschi C, et al, for the European Cooperative Acute Stroke Study (ECASS). Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. JAMA 1995;274:1017-1025.

28.Hacke W, Kaste M, Fieschi C, et al, for the Second European-Australasian Acute Stroke Study Investigators. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 1998;352:1245-1251.

29.Hacke W, Zeumer H, Ferbert A, et al. Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar disease. Stroke 1988;19:1216-1222.

30.Keris V, Rudnicka S, Vorona V, et al. Combined intraarterial/intravenous thrombolysis for acute ischemic stroke. AJNR 2001;22:352-358.

31.von Kummer R, Hacke W. Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke. Stroke 1992;23:646-52.

32.von Kummer R, Allen KL, Holle, et al. Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology 1997;205:327-33.

33.Larrue V, von Kummer RR, Muller A, et al. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke 2001;32:438-41

34.Marler JR, Tilley BC, Lu M, et al. Early stroke treatment associated with better outcome. The NINDS rt-PA Stroke Study. Neurology 2000;55:1649-1655.

35.Nedeltchev K, Brekenfeld C, Remonda L, et al. Internal carotid artery stent implantation in 25 patients with acute stroke: preliminary results. Radiology 2005;237:1029-1037.

36.Neumann-Haefelin T, du Mesnil de Rochemont R, Fiebach JB, et al. Effect of incomplete (spontaneous and postthrombolytic) recanalization after middle cerebral artery occlusion: a magnetic resonance imaging study. Stroke 2004;35:109-14.

37.Mori E, Tabuchi M, Yoshida T, et al. Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery. Stroke 1988;19:802-812.

38.Ramee SR, Subramanian R, Felberg RA, et al. Catheter-based treatment for patients with acute ischemic stroke ineligible for intravenous thrombolysis. Stroke 2004;35:e109-e111.

39.Schmuelling S, Grond M, Rudolf J, et al. One-year follow-up in acute stroke patients treated with rtPA in clinical routine. Stroke 2000;31:1552-1554.

40.Schonewille WJ, Algra A, Serena J, et al. Outcome in patients with basilar artery occlusion treated conventionally. J. Neurol. Neurosurg. Psychiatry 2005;76:1238-1241.

41.Suarez JI, Sunshine JL, Tarr R, et al. Predictors of clinical improvement, angiographic recanalization, and intracranical hemorrhage after intra-arterial thrombolysis for acute ischemic stroke. Stroke 1999;30:2094-2100.

42.Theron J, Coskun O, Huet H, et al. Local intraarterial thrombolysis in the carotid territory. Intervent Neuroradiol 1996;2:111-126.

43.Ueda T, Hatakeyama T, Kohno K, et al. Endovascular treatment for acute thrombotic occlusion of the middle cerebral arter: local intra-arterial thrombolysis combined with percutaneous transluminal angioplasty. Neuroradiology 1997;39:99-104.

44.Ueda T, Sakaki S, Kumon Y, et al. Multivariable analysis of predictive factors related to outcome at 6 months after intr-arterial thrombolysis for acute ischemic stroke. Stroke 1999;30:2360-2365.

45.Yuh WTC, Maeda M, Wang AM, et al. Fibrinolytic treatment of acute stroke: are we treating reversible cerebral ischemia? AJNR 1995;16:1994-2000.

46.Zeumber H, Freitag H-J, Zanella F, et al. Local intra-arterial fibrinolytic therapy in patients with acute stroke: urokinase versus recombinant tissue plasminogen activator (r-tPA). Neuroradiology 1993;31:210-215.

47.del Zoppo GJ, Higashida RT, Furlan AJ, et al and the PROACT Investigators. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke: PROACT Investigators Prolyse in Acute Cerebral Thromboembolism. Stroke 1998;29:4-11.
QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top
無相關期刊
 
系統版面圖檔 系統版面圖檔